MVA Members
Initiator Pharma
Initiator Pharma A/S is a Danish clinical stage life science company developing innovative drugs that target key unmet medical needs within the central and peripheral nervous system. Initiator Pharma’s pipeline consists of three clinical programs – the clinical programs IP2018 and pudafensine for treatment of erectile dysfunction of psychogenic and organic origin, respectively, and the rare disease program IPTN2021 for Trigeminal Neuralgia, a severe neuropathic pain condition.